Opzelura Ruxolitinib Cream 1.5% in Pakistan – Vitiligo Treatment
Opzelura Ruxolitinib Cream is approved for non-segmental vitiligo in adults and children aged 12 years and older in the United States. It may help restore skin pigmentation gradually with consistent treatment under medical supervision.
This advanced dermatological treatment is an option for patients looking for targeted topical therapy for vitiligo.
Benefits of Opzelura Ruxolitinib Cream
- Vitiligo Treatment: Specifically indicated for non-segmental vitiligo.
- Skin Repigmentation: Helps restore natural skin pigmentation in affected areas.
- Targeted Action: Works by inhibiting JAK1 and JAK2 signaling pathways.
- Immune Response Management: Helps regulate immune pathways associated with vitiligo.
- Facial Repigmentation: Can help improve pigmentation in facial areas affected by non-segmental vitiligo.
- Non-Steroidal Formula: Provides a topical treatment option that is not a corticosteroid.
- Long-Term Treatment Support: Visible repigmentation may require more than 24 weeks of consistent treatment.
How To Use Opzelura Ruxolitinib Cream
- Use Opzelura only under the supervision of a qualified dermatologist.
- Apply a thin layer to affected depigmented skin areas.
- The recommended regimen for non-segmental vitiligo is twice-daily application.
- Leave at least 8 hours between applications where required by the applicable product instructions.
- Apply only to the affected areas as directed by your doctor.
- Do not apply to more than 10% of total body surface area.
- Wash your hands after application unless treating your hands.
- Avoid contact with eyes, mouth and other mucous membranes.
- Do not cover treated areas with airtight or occlusive dressings.
- Continue treatment according to your dermatologist's instructions.